Richard Burr actually said...
Tell me why we should reauthorize user fees for pharmaceuticals and devices when, in the case of devices, the length of time has gone up since we instituted user fees?
Context
Questioning the need for reauthorizing user fees due to increased approval times.
07/27/2011